Epclusa contains a combination of sofosbuvir and velpatasvir. Sofosbuvir and velpatasvir are antiviral medications that prevent hepatitis C virus (HCV) from multiplying in your body.
Erwinase (asparaginase Erwinia chrysanthemi) is indicated as a component of a multi-agent chemotherapeutic regimen for the treatment of patients with acute lymphoblastic leukemia (ALL) who have developed hypersensitivity to E. coli-derived Erwinase.
Esbriet (pirfenidone) is used to treat a lung disease called idiopathic pulmonary fibrosis (IPF).
Giotrif is a medicine used to treat a type of lung cancer known as non-small cell lung cancer. The active substance in Giotrif, afatinib, is an ErbB family blocker.
Ibrance (palbociclib) is a cancer medicine that interferes with the growth and spread of cancer cells in the body.
Imfinzi (durvalumab) is a cancer medicine that works with your immune system to interfere with the growth and spread of cancer cells in the body.
Inlyta (axitinib) is a prescription medicine that interferes with the growth of some cancer cells.
Keytruda (pembrolizumab) is a human PD-1 (programmed death receptor-1)-blocking antibody indicated for the treatment of melanoma, non-small cell lung cancer, head and neck squamous cell carcinoma, classical Hodgkin lymphoma, primary mediastinal large B-cell lymphoma, urothelial carcinoma, microsatellite instability-high cancer, gastric cancer, cervical cancer, hepatocellular carcinoma, and Merkel cell carcinoma.
MabThera is the first therapeutic monoclonal antibody to target cells that have the CD20 marker on their surface. These cells are central to many blood cancers, including common forms of lymphoma and leukaemia. MabThera attacks these cells both directly and together with the body’s immune system.
Revlimid (lenalidomide) affects the immune system. It promotes immune responses to help slow tumor growth.
Tagrisso is medicine for treating a lung cancer called non-small cell lung cancer (NSCLC) when the cancer is advanced or has spread. It contains the active substance osimertinib.
Velbe injection contains the active ingredient vinblastine, which is a type of chemotherapy medicine called a vinka alkaloid. It is used to treat various types of lymphomas, as well as some solid tumours.
Yondelis (trabectedin) is indicated for the treatment of patients with unresectable or metastatic liposarcoma or leiomyosarcoma who received a prior anthracycline-containing regimen.
Zepatier contains a combination of elbasvir and grazoprevir. Elbasvir and grazoprevir are antiviral medicines that prevent hepatitis C (HCV) from multiplying in your body. Zepatier is used to treat chronic hepatitis C in adults.
Zometa (zolcdronic acid) Injection is a bisphosphonate used to treat Paget's disease, high blood levels of calcium caused by cancer (hypercalcemia of malignancy), multiple myeloma (a type of bone marrow cancer), or metastatic bone cancer. Zometa is also used to treat or prevent osteoporosis in postmenopausal women, and to increase bone mass in men with osteoporosis.
Zydelig (Idelalisib) is a type of targeted cancer drug (biological therapy).